NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 642316 | ANTINEOPLASTIC-642316 | 0.0406225271888779 | 0.0042511453 |
NSC 666288 | Null | 0.0406225271888779 | 0.0077362309 |
NSC 669145 | 2-Butenoic acid, 2-methyl-, 2,3,3a,4,5,6,7,11a-octahydro- 6,10-dimethyl-3-methylene-2,7-dioxo-6,9-epoxycyclodeca[b]furan-4-yl ester, [3aR-[3aR*,4S*(Z),6R*,10Z,11aR*]]- | 0.0406225271888781 | -0.21242333 |
NSC 671409 | Null | 0.0406225271888781 | 0.36909267 |
NSC 728323 | 16-[3-Methoxy-4-(2-pyrrolidine-1-yl ethoxy)benzylidene]-17-oxo-5-androsten-3a-yl acetate | 0.0406225271888781 | -0.081268654 |
NSC 309895 | Null | 0.0407060322613561 | 0.059784983 |
NSC 670678 | Glutamic acid, N-[4-[[[2-(ethoxycarbonyl)-3-quinoxalinyl] amino]phenyl]carbonyl]-, diethyl ester | 0.0407060322613562 | 0.30732133 |
NSC 711070 | Null | 0.0407060322613562 | 0.5010663 |
NSC 600301 | Null | 0.0407060322613567 | -0.15906541 |
NSC 668814 | 1-Oxa-4,7,10,13,16-pentaazacyclononadecane, cyclic peptide derivative | 0.0462077035966081 | 0.26298413 |